Furthermore, CAMTA1 is a highly-sensitive biomarker that has been used in the differential diagnosis of hepatic epithelioid hemangioendothelioma and angiosarcoma, two vascular tumor types, and low CAMTA1 expression has been associated with poor prognosis in colorectal cancer [11]. This evidence concerns the gene CAMTA1 and colorectal cancer.